Under construction – not a live service
Sign in
Enrolling by invitationNo phase

Tests MINIject implant with cataract surgery for glaucoma and cataract

Tests a MINIject eye implant with cataract surgery in adults with glaucoma.

Plain-language title generated from the registry record
Registry title: MINIject Implantation Combined With Cataract Surgery in Patients With POAG and Cataract

Key facts

Where
Madrid, SpainSee the site

Where in Spain

  • Hospital Clínico San CarlosMadrid, SpainNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
iSTAR Medical
Trial code
NCT05432245
Record updated
28 February 2025
Original description
The study will assess safety and performance of MINIject implant in patients with open-angle glaucoma uncontrolled by topical hypotensive medications in conjunction with cataract surgery.Read full original descriptionShow less

A Prospective, Open, Multicenter Clinical Trial Evaluating the Efficacy and Safety of MINIject Combined With Cataract Surgery in Patients With POAG Uncontrolled by Topical Hypotensive Medications and Operable Age-related Cataract Diagnosis

The study will assess safety and performance of MINIject implant in patients with open-angle glaucoma uncontrolled by topical hypotensive medications in conjunction with cataract surgery.

Inclusion: Diagnosis of primary open angle glaucoma (POAG) in the study eye; Operable age-related cataract eligible for phacoemulsification surgery with Intraocular Lens (IOL) implantation; Glaucoma not adequately controlled with at least one topical hypotensive medication(s), unless the patient has an allergy / intolerance to a medication; Patient must provide written informed consent to participate.

Exclusion: Known or suspected allergy or hypersensitivity to medical silicone; Allergy to fluorescein; Patient has a condition such that his / her ability to provide personal informed consent is compromised; Presence of silicone oil in the study eye; Individuals under tutorship or trusteeship.

ClinicalTrials.gov NCT05432245